Level Bio AB (publ) (NGM:LEVBIO)
Sweden · Delayed Price · Currency is SEK 0.2620
+0.0260 (11.02%)
At close: Sep 23, 2026
Level Bio AB Revenue
Level Bio AB had revenue of 9.20M SEK in the quarter ending June 30, 2026, with 9.80% growth. This brings the company's revenue in the last twelve months to 34.37M, up 14.34% year-over-year. In the year 2025, Level Bio AB had annual revenue of 32.36M with 28.95% growth.
Revenue (ttm)
34.37M
Revenue Growth
+14.34%
P/S Ratio
0.52
Revenue / Employee
3.44M
Employees
10
Market Cap
17.92M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.36M | 7.26M | 28.95% |
| Dec 31, 2024 | 25.10M | -999.39K | -3.83% |
| Dec 31, 2023 | 26.10M | -8.24M | -23.99% |
| Dec 31, 2022 | 34.33M | -9.63M | -21.90% |
| Dec 31, 2021 | 43.96M | 20.43M | 86.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Valuno Group AB | 666.58M |
| Vaxxa AB | 92.78M |
| Transiro Holding AB | 26.57M |
| Qbrick AB | 24.28M |
| Hybricon AB | 16.98M |
| Trainimal AB | 11.94M |
| Holdflight AB | 10.11M |
| StoneBeach Group AB | 8.24M |
Level Bio AB News
- 5 weeks ago - Level Bio AB Quarterly report: Q2 2026 - Filings
- 5 months ago - Level Bio AB Quarterly report: Q1 2026 - Filings
- 7 months ago - Level Bio AB Quarterly report: Q4 2025 - Filings
- 7 months ago - Level Bio AB Annual report: Q4 2025 - Filings
- 11 months ago - Level Bio AB Quarterly report: Q3 2025 - Filings